Spots Global Cancer Trial Database for PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
Official Title: Comparative Clinical and Biochemical Study Evaluating the Effect of Proton Pump I Nhibitors Versus Histamine 2 Receptor Antagonists as an Adjuvant With Chemotherapy in Patients With Non-hodgkin Lymphoma.
Study ID: NCT03647072
Conditions
Study Description
Brief Summary: The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.
Detailed Description: The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump Inhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma to compare the difference in efficacy.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sherief Abd-Elsalam, Cairo, , Egypt
Contact Details
Name: Sahar K Hegazy, Prof
Affiliation: Clinical pharmacy Department- Tanta University
Role: PRINCIPAL_INVESTIGATOR
Name: Sahar M El-Haggar, prof
Affiliation: Clinical pharmacy Department- Tanta University
Role: STUDY_DIRECTOR
Name: Suzan A Alhassanin, Ph D
Affiliation: Clinical Oncology Department-Menoufia University
Role: STUDY_DIRECTOR
Name: Eman I A El berri, Msc
Affiliation: Clinical pharmacy Department-Tanta University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
